Cidara Therapeutics
CDTX
CDTX was delisted on the 6th of January, 2026.
50 hedge funds and large institutions have $42.1M invested in Cidara Therapeutics in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 16 reducing their positions, and 13 closing their positions.
4% more capital invested
Capital invested by funds: $40.5M → $42.1M (+$1.64M)
0.18% less ownership
Funds ownership: 2.08% → 1.9% (-0.18%)
9% less funds holding
Funds holding: 55 → 50 (-5)
25% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 16
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$817K |
| 2 |
Two Sigma Advisers
New York
|
+$813K |
| 3 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$701K |
| 4 |
Two Sigma Investments
New York
|
+$604K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$350K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IVM
InterWest Venture Management
San Francisco,
California
|
-$2.74M |
| 2 |
5VM
5AM Venture Management
San Francisco,
California
|
-$1.66M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$814K |
| 4 |
Millennium Management
New York
|
-$499K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$353K |
CDTX Hedge Fund Activity: Q3 2021 in Review
50 of the 5,727 institutional investors tracked by Wall St. Rank reported a position in Cidara Therapeutics (CDTX) for Q3 2021, worth a combined $42.1M — up 4.1% from $40.5M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of CDTX and 8 opened new positions — a net loss of 5 holders — while 16 trimmed existing stakes and 12 added.
The largest buyer was BVF Inc, adding an estimated $817K. The largest seller was InterWest Venture Management, exiting entirely with an estimated $2.74M sold.
- 50 institutional investors held Cidara Therapeutics (CDTX) as of Q3 2021, down from 55 in Q2 2021.
- Funds reported $42.1M of Cidara Therapeutics stock for Q3 2021, up 4.1% quarter-over-quarter.
- 8 funds opened new Cidara Therapeutics positions in Q3 2021 and 13 closed out, a net change of -5 holders.
- The largest Cidara Therapeutics buyer in Q3 2021 was BVF Inc, an estimated $817K added.
- The largest Cidara Therapeutics seller in Q3 2021 was InterWest Venture Management, an estimated $2.74M sold.
Based on aggregated 13F filings for Q3 2021.